DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 1 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $504,000 | -46.0% | 25,000 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $933,000 | +46.0% | 25,000 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $639,000 | +16.0% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $551,000 | +22.4% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $450,000 | -29.1% | 25,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $635,000 | +38.3% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $459,000 | -16.7% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $551,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 2,062,991 | $7,014,000 | 1.85% |
| RA Capital Management | 2,428,571 | $8,257,000 | 1.01% |
| Omega Fund Management, LLC | 223,457 | $760,000 | 0.49% |
| 683 Capital Management, LLC | 800,000 | $2,720,000 | 0.42% |
| EcoR1 Capital, LLC | 382,000 | $1,299,000 | 0.33% |
| Eventide Asset Management | 377,000 | $1,282,000 | 0.08% |
| Palo Alto Investors LP | 481,519 | $1,637,000 | 0.08% |
| SABBY MANAGEMENT, LLC | 200,000 | $680,000 | 0.04% |
| BOURGEON CAPITAL MANAGEMENT LLC | 13,500 | $46,000 | 0.03% |
| Quotient Investors, LLC | 13,600 | $46,000 | 0.03% |